LighthouseHow Does Awareness of Biomarkers Compare to Prevalence?We compared awareness in oncologists of selected biomarkers to the prevalence of actionable oncogenic mutations across cancers.
LighthouseTrending and Awareness for Merkel Cell CarcinomaWe evaluated trending and awareness for MCC in oncologists and dermatologists over the past decade and found spikes align with treatments.
LighthouseNTRK Trending and Awareness in Community OncologistsWe analyzed trending and awareness patterns of NTRK and NTRK-targeting compounds in academic and community oncologists.